International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches.

Dellgren, Johan L; Persad, Govind; Emanuel, Ezekiel J

Dellgren, Johan L; Persad, Govind; Emanuel, Ezekiel J.

Afiliação

Dellgren JL; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Bergen Centre for Ethics and Priority Setting, University of Bergen, Bergen, Norway.
Persad G; Sturm College of Law, University of Denver, Denver, CO, USA; Bergen Centre for Ethics and Priority Setting, University of Bergen, Bergen, Norway.
Emanuel EJ; Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Bergen Centre for Ethics and Priority Setting, University of Bergen, Bergen, Norway. Electronic address: zemanuel@upenn.edu.

Lancet ; 404(10455): 902-906, 2024 Aug 31.

Article em En | MEDLINE | ID: mdl-39159651

Assuntos

Diabetes Mellitus Tipo 2; Agonistas do Receptor do Peptídeo 1 Semelhante ao Glucagon; Hipoglicemiantes; Humanos; Diabetes Mellitus Tipo 2/tratamento farmacológico; Agonistas do Receptor do Peptídeo 1 Semelhante ao Glucagon/uso terapêutico; Hipoglicemiantes/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Agonistas do Receptor do Peptídeo 1 Semelhante ao Glucagon / Hipoglicemiantes Limite: Humans Idioma: En Revista: Lancet Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google